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The ability to safely and effectively manage reproduction is central to the success of AZA captive‐breeding programs.
Although the AZA Wildlife Contraception Center routinely monitors contraceptive safety, there have been no studies that
compare the effects of contraceptive use to separation of males from females, the other option for preventing reproduction. We
used retrospective medical records and pathology reports submitted by AZA and related facilities for the seven AZA‐managed
canid species to assess rates of uterine pathology relative to female reproductive life histories. Our results showed that the
prevalence of both pyometra and endometrial hyperplasia (EH) was associated not only with treatment with the two most
common contraceptives (Suprelorin® andMGA implants) but also with the number of years barren (i.e., not producing a litter
and not contracepted). Rates of pyometra and EH were especially high in African painted dogs and red wolves, but lowest in
swift and fennec foxes. The number of years producing a litter had a low association, suggesting it could be protective against
uterine pathology. A more recently developed Suprelorin® protocol using Ovaban® to prevent the initial stimulation phase,
followed by implant removal when reversal is desired, may be a safer contraceptive option. These results concerning the
relationship between reproductive management and uterine health have important implications for AZA‐managed programs,
since the unsustainability of many captive populations may be due at least in part to infertility. Managing a female’s
reproductive lifespan to optimize or maintain fertility will require a reconsideration of how breeding recommendations are
formulated. Zoo Biol. 33:8–19, 2014. © 2013 Wiley Periodicals Inc.
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INTRODUCTION
Contraception is central to reproductive management
of many AZA‐managed species, yet finding methods that are
effective, safe, and reversible for the wide range of taxa
needing fertility control remains a challenge. The two
contraceptives most commonly used in female mammals,
deslorelin (Suprelorin®, Peptech Animal Health, Macquarie
Park, Australia) and MGA (melengestrol acetate, Wildlife
Pharmaceuticals, Ft. Collins, CO) implants are effective in
most species. However, in the 1990’s MGA implants and
other progestin‐based contraceptives were shown to carry
risk of uterine and mammary pathology in felids
[Munson, 2006] and likely in other carnivores as well
[Chittick et al., 2001; Moresco et al., 2009]. GnRH agonists
such as Suprelorin® were not in wide use at the time of the
Moresco canid study, so were not included in that analysis.
Suprelorin®, a GnRH agonist that had been developed
and tested in domestic dogs and cats [Trigg et al., 2001;
Rubion et al., 2006] became available to the zoo community
*Correspondence to: Cheryl Asa, Research Department, Saint Louis
Zoo, 1 Government Drive, St. Louis, MO 63110. E‐mail: asa@stlzoo.
org
Received 12 December 2012; Revised 18 January 2013; Accepted 06
February 2013
DOI: 10.1002/zoo.21069
Published online 1 April 2013 in Wiley Online Library
(wileyonlinelibrary.com).
© 2013 Wiley Periodicals, Inc.
Zoo Biology 33: 8–19 (2014)
around 2000. Because its mechanism of action is down‐
regulation of the pituitary–gonadal axis, in the absence of
estrogen and progesterone [Herbert and Trigg, 2005], uterine
and mammary tissue stimulation should not occur. Thus,
Suprelorin® was considered a safe alternative for wild
carnivores.
The AZA Wildlife Contraception Center (WCC)
distributes an annual survey on contraceptive use in zoos
and aquaria and encourages those institutions to contact the
WCC when questions or problems arise regarding the use of
contraceptive products. Early in 2009 the WCC received
several reports of pyometra, a potentially life‐threatening
uterine infection, in African painted dogs (Lycaon pictus) and
red wolves (Canis rufus), but it was unclear whether the
infections might be associated with contraceptive use or
merely reflect a tendency in those species. For example,
Moresco et al. [2009] found a higher likelihood of pathology
of the uterine endometrium (including pyometra) in painted
dogs than in other wild canids, regardless of prior treatment
with progestins. This species difference may be similar to the
higher risk of pyometra seen in some domestic dog breeds
[Smith, 2006; Hagman et al., 2011].
If undetected or untreated, pyometra can result in death.
The usual treatment is surgical removal of the uterus and
ovaries,which prevents future reproduction even though itmay
spare the life of the mother. The typical procedure of removing
the ovaries also precludes the option of future gamete rescue.
Regardless, the female is removed from the breeding
population, which can have profound effects on the success
and sustainability of the program, particularly if the female is
genetically valuable. Even with medical treatment instead of
surgery, future fertility may be compromised [Meyers‐Wallen
et al., 1986]. Given the serious implications of this condition
for female health and fertility, it is critical that we better
understand the factors affecting its occurrence.
The most prevalent uterine lesion found in zoo canids
in an earlier study [Moresco et al., 2009] was endometrial
hyperplasia (EH). There is some controversy about the
association between EH and pyometra in domestic dogs, the
model available for understanding the condition in wild
canids [De Bosschere et al., 2001]. The traditional dogma is
that EH is a pre‐condition for pyometra [Verstegen
et al., 2008], yet not all cases of EH proceed to pyometra
and pyometra sometimes develops in the absence of EH.
Particularly during the luteal phase of the reproductive cycle,
when progesterone is elevated, a variety of physical,
biological, and chemical substances have been shown to
cause uterine endometrial irritation which can develop into
pyometra in domestic dogs [De Bosschere et al., 2001].
The endocrine milieu that favors development of both
EH and pyometra is elevated progesterone, further enhanced
by estrogen priming [Teunissen, 1952], the natural pattern of
hormone secretion during estrus and diestrus (following
ovulation) in canids. Canids are unusual in that ovulation is
followed by a very protracted, 2‐month diestrous phase with
elevated progesterone, a period equivalent to gestation
[Asa, 1999]. This is in contrast to most other mammalian
species that typically have a diestrous period of only about
2 weeks. Thus, the canid uterine endometrium is primed by
estrogen then exposed to a long period of progesterone
stimulation creating conditions favorable to supporting and
nourishing embryos, conditions also ideal for pathogen
growth. Even in the absence of infection, repeated non‐
conceptive cycles favor development of EH.
Thus, understanding and diagnosing EH in canids is
important, because even when it does not lead to pyometra, it
can be implicated in infertility. Changes in the integrity of the
uterine endometrium associated with EH can compromise
implantation and pregnancy maintenance. The primary risk
factor for EH and pyometra is exposure to progesterone
during natural cycles or treatment with synthetic progestins,
for example MGA implants for contraception. Treatment
with Suprelorin® has been assumed to be equivalent to one
natural cycle, because as a hormone agonist, it can first
stimulate estrus and ovulation before achieving down‐
regulation. Risk should be lower when the stimulation phase
is prevented by 2 weeks treatment with the oral synthetic
progestin megestrol acetate (Ovaban®: Schering‐Plough
Animal Health, Union, NJ) [Wright et al., 2001] and lowest
following pregnancy and birth, since parturition is followed
bymore complete endometrial remodeling than non‐pregnant
cycles.
To assess possible risk factors, the WCC undertook a
retrospective survey and analysis of the prevalence of both
endometrial hyperplasia (EH) and pyometra in the seven
AZA‐managed canid species: African painted dogs; fennec
(Vulpes zerda) and swift (V. velox) foxes; Mexican (C. lupus
baileyi), red and maned (Chrysocyon brachyurus) wolves;
and bush dogs (Speothos venaticus). We compared the
reproductive and contraceptive histories of females to
documentation of EH or pyometra in medical records and
pathology reports contributed by participating institutions.
We predicted that the risk of EH and pyometra would be
higher in females treated withMGA implants or experiencing
more non‐conceptive cycles (i.e., separated frommales rather
than contracepted), moderate in females treated with
Suprelorin® alone, and lower in females producing more
litters or treated with Suprelorin® plus Ovaban®.
METHODS
Data Collection
We requested medical records and pathology reports
for female African painted dogs, bush dogs, fennec foxes,
maned wolves, Mexican gray wolves, red wolves and swift
foxes held in North American zoos. Three species (painted
dog, bush dog, and maned wolf) have only International
Studbooks, but only animals housed in North American zoos
were included. For North America, in general, non‐AZA zoos
were excluded unless the coordinator of the respective AZA
Species Survival Plans® (SSP) deemed them to be important
holding institutions that had records of sufficient quality. We
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set the date range for the records based on estimations of the
numbers of animals and likely quality of data. That is, the
various canid species became numerous in AZA institutions
at different times, SSPs were established on different dates,
and SSP status was expected to be associated with better
record‐keeping. Other factors affecting the thoroughness of
record‐keeping and potential availability of records, which
could vary by institution and by species, were when or
whether there was at least one full‐time veterinarian on staff
and the time when medical animal record keeping system
(MedARKS) started being used.We asked the respective SSP
coordinators to consider these factors and recommend start
dates, that is, the earliest records wewould request. Start dates
for records differed among species due to differences in their
respective SSPs (Table 1); end date was close of the request
period, December 15, 2010.
Generating Reproductive Histories
Reproductive histories were created for each female
using a variety of sources. Data on birth dates, litters born,
and inter‐birth intervals were obtained from single population
animal record keeping system (SPARKS). The analyses
included only a female’s reproductive lifespan, that is, the
years she would have been exposed to reproductive hormones
and/or contraceptives. Reproductive lifespan was calculated
by subtracting age of puberty for the species from the
female’s age at death, age at ovariohysterectomy (OVH) or
age on date of last medical record for females still living.
Females that died or were ovariohysterectomized before
puberty were excluded from the analysis. Age of puberty was
calculated from the species’ studbooks (Table 1).
Because the possible number of reproductive cycles per
year or number of litters per year might affect the condition of
the uterine endometrium, we used studbook data to calculate
inter‐birth intervals for each species. We looked for the
shortest interval between births for each species, ignoring
outliers (e.g., intervals less than gestation plus estrus for the
species), with the assumption that females in good health
could cycle (ovulate) at those intervals. We then used that
number to calculate the mean number of cycles a female of
that species could have per year if she did not conceive and
produce a litter, which would approximate the number of
estrous and luteal phases her uterus would experience
(Table 1). Since several of the species are strict seasonal
breeders constrained to only one ovulation or litter per year,
this approach allowed us to characterize the reproductive data
by year (for seasonal breeders) or by a fraction of a year (for
non‐seasonal breeders) for analysis.
The number of years a female did not produce a litter
and was not contracepted is not reported in any database. That
information is critical to a comparison of risk factors, since
other than contraception, the management alternative for
avoiding production of a litter is separation of females from
males. Thus, it is important to establish the relative health
risks of a female remaining barren but not treated with a
contraceptive. To generate those data we added the number of
years each female produced a litter to the number of years she
was treated with a contraceptive, then we subtracted that sum
from her reproductive lifespan.
Contraception information was gathered from the AZA
Wildlife Contraception Center Database. Contraceptive
analysis only included MGA and Suprelorin® implants;
although some individuals had been treated with Lupron
Depot® (leuprolide acetate: TAP Pharmaceuticals, Chicago,
IL) or with Depo‐Provera® (medroxyprogesterone acetate:
Pfizer, New York, NY), there were too few cases for
statistical analysis. However, the two different protocols for
Suprelorin® treatment were analyzed separately: Supre-
lorin® only or Suprelorin® plus Ovaban® (megestrol
acetate). Giving megestrol acetate (MA) for 1 week before
and 1 week after Suprelorin® implant insertion counters the
stimulation phase to prevent estrus and ovulation, which
would then be followed by approximately 2 months of
elevated progesterone. Thus, the hormonal milieu accompa-
nying the first 3 months of treatment differs considerably
between the two protocols, which could have different effects
on the uterine endometrium.
Based on calculation of average reversal times for
MGA implant use in canids recorded in the WCC database,
when implants were not removed, mean duration of efficacy
was approximately 3 years. Thus, if MGA implants were not
removed, duration of efficacy was assumed to be 3 years;
otherwise, time of implant removal was used as the end time.
For Suprelorin®, with or without megestrol acetate, duration
of efficacy was designated as 6 months for the formulation
designated as a 6‐month implant and as 12 months for the
formulation designated 12‐months. Although this may
TABLE 1. Date ranges for records and parameters comprising reproductive histories, by species
Species Record start date Record end date
Age at puberty
(month)
Interbirth interval
(month)
Mean no. of
cycles/year
Painted dog 1/1/1990 12/15/2010 22 8 1.5
Bush dog 1/1/1960 12/15/2010 10 7 1.7
Fennec fox 1/1/1995 12/15/2010 10 7.5 1.6
Maned wolf 1/1/1984 12/15/2010 22 12 1
Mexican wolf 1/1/1984 12/15/2010 22 12 1
Red wolf 1/1/1984 12/15/2010 22 12 1
Swift fox 1/1/1984 12/15/2010 10 12 1
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underestimate the duration of suppression, especially for non‐
seasonally breeding species, there have been insufficient data
on Suprelorin® reversals reported for canids for quantifica-
tion. When successive Suprelorin® implants, without
megestrol acetate, were placed within 6 or 12 months for
those formulations, respectively, we assumed there was
continuous down‐regulation and no additional stimulation
phase.
Thus, the variables that comprised each female’s
reproductive lifespan were: number of years producing a
litter, number of years treated with a contraceptive (MGA,
Suprelorin®, or Suprelorin® plus megestrol acetate, as
separate variables), and number of years not producing a litter
and not contracepted (i.e., number of barren years).
Extraction of Data From Medical Records and
Pathology Reports
Designation of pyometra was standardized based on
clinical observations, bacterial culture, and pathological
findings. Clinical signs of open pyometra included vulvar
discharge with possible additional signs of lethargy,
depression, anorexia, polyuria, polydipsia, vomiting, or
diarrhea [Renton et al., 1993; Pretzer, 2008]. Clinical signs
of closed pyometra were expected to be more marked, with
possible systemic illness due to bacterial toxins in the intra‐
luminal fluid of the uterus [Pretzer, 2008]. Evidence of
enlarged uterus by radiograph or ultrasound or a pus‐filled
uterus following OVH or during necropsy provided further
diagnostic confirmation. The bacterium most frequently
isolated in canine pyometra isEscherichia coli [De Bosschere
et al., 2001], although it was considered confirmation rather
than requisite for definitive diagnosis. All animals were cross‐
referenced to pathology results from the Wildlife Contracep-
tion Center‐Health Surveillance Program database [estab-
lished by L. Munson and maintained by A. Moresco].
Statistical analysis was based on pyometra diagnoses of
Yes, No, or Suspected, based on clinical, bacterial culture,
and gross histopathological findings. We did not consider
gross inspection alone to be adequate for a positive diagnosis
of pyometra (Yes); cytologic or histologic confirmation was
necessary. We assigned cases with clinical signs (e.g., fever,
discharge from vulva) and gross observation of the uterus
suggestive of pyometra but without histopathology results as
Pyometra Suspected.
Designation of EH was also standardized. Because EH
can be a chronic, subclinical condition [De Bosschere
et al., 2001] that is difficult to diagnose without histopathol-
ogy, the diagnosis of EH was based solely on histological
data in reports from necropsy or post‐OVH.
Statistical Analyses
All data were compiled in an Access relational database
(Microsoft 2007) to allow integration of the variables. The
development of uterine endometrial pathology, either
pyometra or endometrial hyperplasia, is the result of complex
interactions among factors such as the individual animal’s
physiology, exposure to either endogenous (natural repro-
ductive cycles) or exogenous hormones (various contracep-
tive treatments), and its reproductive history. This complexity
is represented in the way the data were collected and the
database assembled. In recent years there has been tremen-
dous criticism of the application of classical inferential
statistics to this type of data that were not collected to test
specific hypotheses [Anderson et al., 2000; Anderson and
Burnham, 2002; Whittingham et al., 2006]. To assess the
relative contribution of each factor, we used a multi‐model
inference approach [Anderson and Burnham, 2002; Burnham
et al., 2011]. Using an information‐theoretical method allows
multiple hypotheses to be assessed with the application of a
parsimony contrast [Whittingham et al., 2006; Burnham
et al., 2011].
We used a generalized linear model (GLM) frame-
work in the R statistical environment (v. 2.14.2, R
Development Core Team 2012) with a multi‐model
selection step function. Those models with the lowest
Akeike’s information criterion (AIC) are considered the
most parsimonious [Link and Barker, 2006]. This approach
compares multiple models by estimating the difference
between the information criterion and the data: DAIC
[Anderson and Burnham, 2002]. Models with DAIC
between 0 and 2 have the most evidentiary support. Only
those models with a DAIC less than 2 were retained for
further evidentiary analysis, that is, model parameter weight:
wi [Anderson and Burnham, 2002]. We performed multi‐
model selection analysis for each pyometra and for EH, first
using the data for all species combined, then on a species‐
by‐species basis (Table 1). The analysis was run twice for
pyometra, first with Pyometra Suspected cases included with
Pyometra Yes, then with Pyometra Suspected cases included
with Pyometra No. There were too few cases to permit
analysis of Pyometra Suspected as a separate factor. For
species that did not have enough positive pyometra or EH
cases for analysis, descriptive statistics are provided.
A contingency test (G‐test) was used to assess the
prevalence of pyometra in each species relative to the
population, which combined data for all the species. The
parallel assessment for endometrial hyperplasia used an
adjusted G‐test [Sokal and Rohlf, 1981]. An Aspin–Welch
unequal variance t‐test (NCSS, Kaysville, Utah) was used to
compare the number of pyometra‐positive and ‐negative
females for age at first reproduction, for number of litters, and
for number of reproductive years with no litters and no
contraception.
RESULTS
The results for pyometra represent 775 records for the
seven canid species. Records were requested from 1,027
females but received for only 871. Reasons for missing
records were (1) the institution did not respond, or (2) the
female’s records had been lost. We excluded females that
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died before or very soon after the time of puberty, so had not
experienced a reproductive cycle. Only 290 pathology reports
included histology results for the uterine endometrium
following death or surgical removal of the uterus, which
was necessary to diagnose endometrial hyperplasia.
Pyometra
A general linear model (GLM) with a multimodel
inference approach was used to evaluate factors associated
with pyometra. The first analysis combined suspected and
positive cases of pyometra. We combined and analyzed data
for six of the seven species (Table 2; there were too few cases
of pyometra in swift foxes to meet the criteria for analysis).
The results suggest that the strongest support was for the
model that retained MGA implants and Suprelorin®, with
some support also for number of years barren. Still, MGA and
Suprelorin® had greater support than when number of years
barren was added to the multimodel inference. Examination
of the weights (wi) for all species shows that 87% of the
variance can be explained by these factors. The GLMwas run
again but with suspected cases of pyometra added to those
negative for pyometra. The results indicate the strongest
support for the model retained years barren and MGA
implants, explaining 49% of the variance (Table 2). All
subsequent results presented are for analyses where suspected
pyometra was classified as Yes.
There were sufficient data for GLM analyses of painted
dogs, red wolves, and Mexican wolves (Table 2). For painted
dogs, the strongest support was for number of years treated
with MGA implants or Suprelorin®; number of years
producing a litter had a negative value, indicating a negative
association with pyometra. For red wolves, years barren or
treated with Suprelorin® had the strongest support, which
accounted for 80% of the variance. For Mexican wolves,
years treated with MGA implants or Suprelorin® had
strongest support, accounting for 89% of the variance.
Rates of pyometra for all animals, regardless of
reproductive history, ranged from a high of 23.5% to a low
of 1.6% (Table 3 and Fig. 1a). The rate was significantly
higher in painted dogs (G¼ 244.6, P< 0.0001) than that of
the population, but significantly lower in swift (G¼ 128.0,
P< 0.0001) and fennec foxes (G¼ 73.3, P< 0.0001),
respectively. Mean age at birth of first litter (for those
females that had given birth at least once) was significantly
different between pyometra positive and negative cases only
for bush dogs (Fig. 2a). Although the difference appears
significant for swift foxes, only one female was positive for
pyometra.
In the dataset analyzed for pyometra, most females
treated with a contraceptive received only one type of product
(n¼ 139), but 19 (13.7%) received more than one type
(Table 4). Of the 65 total number of cases (all species)
positive for pyometra, 31 females (47.7%) had been treated
with a contraceptive at least once, but 34 (52.3%) had never
been treated with any contraceptive product. Of the reports
negative for pyometra, 127 out of 710 females (17.9%) had
been treated with contraceptives. For females treated with
contraceptives, the duration of treatment ranged from about
6 months to almost 6 years for MGA implants, from about
TABLE 2. Results of GLM multimodel analyses for factors associated with pyometra or endometrial hyperplasia (EH)
Model DAIC wi
Pyometraa
All species MGAþSuprelorin® 0 0.56
MGAþ Suprelorin®þ barren 2.4 0.31
Painted dog LittersþMGAþ Suprelorin® 0.3 0.22
Red wolf Suprelorin®þ barren 0 0.80
Mexican wolf MGA 0 0.77
MGAþSuprelorin® 1.4 0.12
Pyometrab
All species BarrenþMGA 0.4 0.49
Endometrial hyperplasia
All species Littersþ barrenþMGA 0 0.27
Painted dog MGA 0 0.31
MGAþ barren 1.13 0.08
Red wolf Barren 0 0.15
aPyometra Suspected added to Pyometra positive diagnosis.
bPyometra Suspected added to Pyometra negative diagnosis.
TABLE 3. Relative rates of pyometra and endometrial
hyperplasia (EH) by speciesa
Species
Incidence of
pyometrab (%)
Incidence of
EH (%)
Painted dog 23.5 40
Bush dog 9.4 15
Fennec fox 2.7 9.1
Maned wolf 5.6 100
Mexican wolf 3.9 37.5
Red wolf 11.1 75
Swift fox 1.6 0
Total 8.4 38.1
aCombines data for all reproductive life history variables.
bIncludes suspected and confirmed cases.
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6months to 2 years for Suprelorin®, and from about 6months
to 3 years for Suprelorin® plus MA.
There was an insufficient number of cases of females
treated with Suprelorin® plusMA for statistical analysis of its
relationship with pyometra, but the association appears to be
low. Of cases positive for pyometra (see Table 4) only five
female painted dogs had received this combination and four
of those had also been treated previously with either MGA
implants or Suprelorin® only. Thus, only one female that was
positive had been treated solely with Suprelorin® plus MA.
In contrast, 23 females negative for pyometra had been
treated with the Suprelorin® plus MA combination. A higher
percentage of positive cases were associated with MGA or
Suprelorin®‐only treatment than Suprelorin® plus MA:
16.4% of females treated only withMGA implants and 18.6%
of females only treated with Suprelorin® alone, compared to
7.7% of females only treated with Suprelorin® plus MA.
To evaluate the rate of pyometra associated solely with
reproductive cycles, we compared the subset of females that
had never been treated with a contraceptive and had never
produced a litter, that is, females that we assumed had
experienced repeated ovulatory cycles throughout their lives
post‐puberty. The rates of pyometra in these females and their
relative ages (as number of reproductive years post‐puberty) at
the time of diagnosis are presented in Table 5. The number of
cases varied by species, but species differences in pyometra
rates in this sub‐group of females were apparent. There were
only two species (painted dogs and red wolves) with more
than one female positive for pyometra in this data subset.
Painted dogs had the highest rate (18.6%), followed by red
wolves (10.4%), while fennec foxes and Mexican wolves had
the lowest rates (Table 5). For the two species with enough
cases for statistical comparison, there was no difference for
pyometra‐positive or ‐negative painted dogs in this data subset
on mean number of reproductive years, but pyometra‐positive
red wolves were significantly older (more reproductive years)
than those that were negative (P< 0.0001). Although there
was an insufficient number of positive cases for the other
species, it is interesting to note that the minimum number of
reproductive years at diagnosis was above 8 reproductive
years for all but painted dogs, red wolves, and bush dogs,
where minima were 2.3, 3.1, and 3.7 years, respectively. That
Fig. 1. (a) and (b) Comparison of the prevalence by species of (a)
pyometra and (b) endometrial hyperplasia (EH); bars with different
superscripts are significantly different.
Fig. 2. (a) and (b) Comparison by species of the mean age at first
reproduction among females diagnosed with (a) pyometra or (b)
endometrial hyperplasia (EH); *Significant difference between
positive and negative cases for that species.
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is, not only was the rate of pyometra high for painted dogs and
red wolves in this data subset, but they appeared likely to be
diagnosed with pyometra at a relatively young age.
Endometrial Hyperplasia
Fewer records were available for analysis of EH than
for pyometra, which limited the options for statistical
analyses. As for pyometra, a GLM with a multimodel
inference approach was used to evaluate factors associated
with EH.We combined and analyzed data for six of the seven
species (there were no cases of EH reported for swift foxes).
The results suggest that the strongest support was for the
model that retained number of years producing a litter, treated
with MGA implants and barren (Table 2). However, this
accounted for only 27% of the variance, indicating the
TABLE 4. Comparison of the number of positive and negative cases of pyometra in females treated with contraceptives
Total N
MGA implants
(only/ever)a
Suprelorin®
(only/ever)
Suprelorin®þMA
(only/ever)
More than one
contraceptive
Painted dog
Pyometra Yesb 23 5/7 2/4 1/5 4
Pyometra No 75 12/13 2/5 3/7 4
Bush dog
Pyometra Yes 3 0 0 0 0
Pyometra No 29 0 0/1 1/2 1
Fennec fox
Pyometra Yes 3 0 0 0 0
Pyometra No 110 1/6 4/6 2/5 5
Maned wolf
Pyometra Yes 6 1/1 0 0 0
Pyometra No 101 6/7 4/6 0/3 3
Mexican wolf
Pyometra Yes 6 0/2 0/2 0 0
Pyometra No 149 2/2 12/13 3/3 1
Red wolf
Pyometra Yes 23 4/4 6/6 0 0
Pyometra No 184 29/30 12/13 3/3 1
Swift fox
Pyometra Yes 1 0 0 0 0
Pyometra No 62 1/1 1/1 0 0
Totals
Pyometra Yes 65 10/14 8/12 1/5 4
Pyometra No 710 51/59 35/45 12/23 15
aOnly¼ female was only treated with this type of contraceptive and no other; Ever¼ female was ever treated with this type of contraceptive,
so may have also been treated with another.
bIncludes suspected and confirmed cases.
TABLE 5. Comparison of positive and negative cases of pyometra among females never treated with a contraceptive and never
producing a litter
Number of
negative
pyometra cases
Percent of
negative
cases (%)
Mean (SE)
reproductive
yearsa (range)b
Number of
positive
pyometra
cases
Percent of
positive cases (%)
Mean (SE)
reproductive
yearsa (range)c
Painted dog 35 81.4 5.5 0.5 (1.5–10.3) 8 18.6 5.5 0.8
(2.3–9.5)
Bush dog 16 94.1 5.0 0.6 (0.7–10.8) 1 5.9 3.7
Fennec fox 67 98.5 7.8 0.5 (0.8–14.7) 1 1.5 8.3
Maned wolf 47 97.9 5.9 0.5 (0.7–13.73) 1 2.1 12.6
Mexican wolf 91 98.9 5.0 0.3 (0.7–14.8) 1 1.1 9.2
Red wolf 69 89.6 3.8 0.4* (0.8–12.9) 8 10.4 9.8 0.7*
(3.1–13.8)
Swift fox 33 100 5.6 0.6 (1.1–12) 0 NA NA
aNumber of reproductive years¼ number of years beyond puberty.
bRange in number of reproductive years of females in medical records not diagnosed with pyometra.
cRange in number of reproductive years of females in medical records diagnosed with pyometra.
*Significantly different (P< 0.0001).
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association was weak overall. At the species level, there only
were sufficient data for analyses for painted dogs and red
wolves. For painted dogs, the strongest support was for MGA
implants followed by number of years barren; these
accounted for 39% of the variance. For red wolves the
strongest support was for years barren, but this accounted for
only 15% of the variance.
Rates of EH ranged from a high of 100% (maned
wolves) to 9% (fennec foxes; Table 3). No histology results
were submitted for swift foxes. These differences in
prevalence were significantly greater for red wolves
(G¼ 0.0001, P< 0.05) and significantly lower for fennec
foxes (G¼ 10.69, P< 0.05) and bush dogs (G¼ 10.58,
P< 0.05). Although the prevalence for maned wolves was
100%, they could not be included in the contingency test
because the number for negative cases of EH was zero.
In the subset of data analyzed for EH, most females
treated with a contraceptive received only one type of product
(n¼ 53), but 10 received more than one type (Table 6). Of the
80 total cases positive for EH, 32 females (40%) had been
treated with a contraceptive at least once, but 48 (60%) had
never been treated with any contraceptive product. Of the
records negative for EH, 31 out of 130 females (23.8%) had
been treated with contraceptives.
Age at first reproduction between females positive and
negative for EH differed significantly (P< 0.05) only for
bush dogs (Fig. 2b). Statistical comparison was not possible
for maned and red wolves. Only EH‐positive reports were
submitted for maned wolves, and their mean age was within
the range reported for the other three species (5.5 years). Only
one red wolf negative for EH had produced a litter.
There was an insufficient number of cases of females
treated with Suprelorin® plus MA for statistical analysis of
its relationship with EH, but as with pyometra the asso-
ciation appears to be low. Of cases positive for EH (see
Table 4) only five females (four painted dogs and 1 bush
dog) had received this combination, and two of the painted
dogs had also been treated with either MGA implants or
Suprelorin® only.
DISCUSSION
The pattern emerging from our various analyses is that
the prevalence of uterine pathology was higher for females
that spent more years not reproducing. Although the ranking
of risk factors varied somewhat among species, the factors
that were consistently high were years contracepted with
either MGA or Suprelorin® implants or years barren (i.e., not
producing a litter and not contracepted). In contrast, years
producing a litter were generally not associated with uterine
pathology or even found to be protective.
Analysis of the full dataset for all seven species using
GLM multimodel inference showed that the prevalence of
pyometra (combining positive and suspected categories of
TABLE 6. Comparison of the number of positive and negative cases of endometrial hyperplasia in females treated with a
contraceptive versus those never treateda
Total N
MGA implants
(only/ever)a
Suprelorin®
(only/ever)
Suprelorin®þMA
(only/ever)
More than one
contraceptive
Painted dog
EH Yes 24 7/8 1/2 2/4 2
EH No 36 4/4 3/5 0/2 2
Bush dog
EH Yes 3 0 0 1/1 0
EH No 17 0 0/1 0/1 1
Fennec fox
EH Yes 6 0/1 0/1 0 1
EH No 60 1/4 3/4 2/4 3
Maned wolf
EH Yes 14 1/1 0 0 0
EH No — — — — —
Mexican wolf
EH Yes 3 0 0 0 0
EH No 5 1/1 0 0 0
Red wolf
EH Yes 30 9/10 3/4 0 1
EH No 10 3/3 2/2 0 0
Swift fox
EH Yes — — — — —
EH No 2 0 0 0 0
Totals
EH Yes 80 17/20 4/7 3/5 4
EH No 210 9/12 8/12 2/7 6
aOnly¼ female was only treated with this type of contraceptive and no other; Ever¼ female was ever treated with this type of contraceptive,
so may have also been treated with another.
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pyometra) was highest for years treated with MGA implants
and next highest for years treated with Suprelorin® implants,
the two contraceptive products used most commonly in these
species. Results of GLM multimodel inference at the species
level revealed some differences among species but consider-
able overlap as well. For painted dogs and Mexican wolves,
highest incidence of pyometra was associated with years
treated with MGA implants, but for red wolves the highest
incidence was associated with the number of years barren
(i.e., not producing a litter and not contracepted), followed by
years treated with Suprelorin®. These species differences
may have been influenced by the number of years each
species was exposed to the specific contraceptive product or
years spent barren.
When we repeated the GLM analysis with the full
dataset, using the more conservative approach of considering
suspected (not confirmed) cases of pyometra to be negative,
the highest incidence of confirmed pyometra was associated
with years barren and years treated with MGA implants. The
analysis using this definition for pyometra diagnosis differed
from the other only in ranking the number of barren years
higher than Suprelorin® years. The overall results showing
the association of barren years with uterine pathology have
especially important implications for reproductive manage-
ment. Although contraception may be viewed as an artificial
and therefore more risky approach, in fact, preventing a
female from reproducing by separation frommales can have a
similar outcome as the use of some contraceptives.
In the GLM multimodel analysis of cases of
endometrial hyperplasia, number of years barren and years
treated with MGA implants were again the factors showing
the strongest association with uterine pathology. This trend
continued with painted dogs and red wolves that had
sufficient uterine histology data for analysis at the species
level. However, the number of years producing a litter
appearing as a factor in the combined‐species model seems
anomalous, since it did not appear as an important factor in
any other models for EH or pyometra (Table 2) and in fact
was negative in one, indicating a negative association or even
a protective effect. In this model, support for litter years was
not very strong, likely due to the small dataset. This limitation
could be addressed by more zoos submitting reproductive
tracts to the Reproductive Health Surveillance Program
associated with the AZA Wildlife Contraception Center
(www.stlzoo.org/contraception).
The similarity of results for pyometra and EH is not
surprising, since EH is often considered a condition that can
predispose to pyometra, and EH can develop following
inflammation [Verstegen et al., 2008]. In the normal
reproductive cycle, after estrogen priming during the estrous
phase, progesterone production throughout the luteal phase
following ovulation prepares the uterine endometrium to
nourish developing embryos. That environment is also
favorable to the growth of bacteria, if they are able to gain
access, as occurs with pyometra. Melengestrol acetate, the
active ingredient in MGA implants, is a synthetic progestin
with effects similar to progesterone. Thus, treatment with
MGA can stimulate endometrial growth and produce
conditions that can favor development of EH and pyometra.
We expected Suprelorin® (deslorelin, a GnRH agonist)
to be a safer contraceptive option, since the prolonged period
of uterine stimulation that accompanies MGA implant
treatment (2 or more years per implant) is avoided. However,
as an agonist, Suprelorin® first stimulates the reproductive
axis, which can result in ovulation followed by prolonged
progesterone production during the subsequent luteal phase.
Nevertheless, we expected the approximately 2‐month
induced luteal phase to be roughly equivalent to a normal
luteal phase, not adding to risk above that of a typical cycle.
More importantly, 2 months is a considerably shorter period of
progesterone exposure than the continuous release of progestin
from an MGA implant. Thus, we were surprised to find that
Suprelorin® treatment was associated with both pyometra and
EH at about the same level as MGA implants. This might be
explained by results of studies of domestic dogs, which have
shown that estrogen priming followed by progesterone had a
more profound effect on the uterus than either estrogen or
progesterone alone [Teunissen, 1952]. Therefore, a cycle
stimulated by Suprelorin®, or even natural cycles, with
estrogen priming preceding 2 months of elevated progester-
one,might have asmuch if notmore effect on the endometrium
than long‐term progestin treatment initiated (e.g., MGA
implants) during anestrus, when estrogen would be very low.
Understanding the specific effects of contraceptives is
complicated by several factors. Because these were retro-
spective analyses, the variables were neither controlled nor
equal within or across species. In addition, some individuals
were treated only once while others were treated for several
years, and some females were treated with more than one
contraceptive in succession. Animals were of different ages,
with different reproductive histories, for example, number
and frequency of litters produced, and age of first
reproduction. In addition, there was no way to determine
whether non‐reproductive females were having normal
ovulatory cycles. Despite these caveats, the accumulated
data do show that the two most commonly used contraceptive
treatments were associated with increased risk of uterine
pathology. However, it is important to note that uterine
pathology occurred even in females never treated with a
contraceptive.
The risk of pyometra increases with age in domestic
dogs [Fukuda, 2001]. However, age (number of reproductive
years in this analysis) was not statistically associated with
uterine pathology except in red wolf females never treated
with contraceptives, that is, those positive for pyometra were
significantly older. Statistical analyses were often limited by
the small number of cases, but in a comparison of nulliparous
females that were never treated with contraceptives, most
animals had experienced many years of reproductive cycles
when pyometra was diagnosed (Table 5). Exceptions were
seen in a few painted dogs and red wolves as well as one bush
dog, adding to the pattern of painted dogs and red wolves, in
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particular, not only appearing to be more vulnerable to the
development of uterine pathology but perhaps at younger
ages. These females had undergone only natural reproductive
cycles, affected just by endogenous hormones, with no
exposure to contraceptives. These results are comparable to
those reported for domestic dogs, that is, an increased
prevalence of pyometra in females that undergo repeated
natural cycles [Niskanen and Thrusfield, 1998].
In each type of analysis, there was a trend for higher
rates of uterine pathology in painted dogs and redwolves. The
prevalence of both pyometra and EH was significantly higher
in these two species relative to the population of canids
analyzed, regardless of reproductive history. In particular,
this outcome for painted dogs is consistent with the report by
Moresco et al. [2009], suggesting a species susceptibility. In
contrast, swift and fennec foxes had the lowest rates of
pyometra and EH, but there was only one histology report
submitted for swift foxes by which to judge EH.
One approach to assessing possible reasons for these
species differences is to compare their natural reproductive
patterns. For example, the number of days of annual
progesterone exposure is a function of the number of cycles
per year and the relative length of the luteal phase. In canids,
the luteal phase is roughly equivalent to the length of
gestation. For the two fox species gestation is about 52 days
[Asa, 1999; Asa and Valdespino, 2003], whereas in red
wolves it is about 62 days and in painted dogs about 72 days
[Newell‐Fugate et al., 2012]. Thus, the red wolf and painted
dog would be exposed to progesterone about 10 and 20 days
more per cycle, respectively, than the foxes. However,
although the swift fox ovulates only once annually, the fennec
can have more than one cycle per year [Valdespino
et al., 2002], which would increase its exposure to
endogenous progesterone. The painted dog has both a
relatively long luteal phase and can also, in some instances,
have a second cycle in 1 year [Frame et al., 1979], perhaps
exposing it to more progesterone annually than the other
canid species. However, those cases usually involve a second
cycle when the current litter is lost, which means the prior
cycle was not a barren cycle but a pregnancy, which should
have been protective against uterine pathology. The case is
best for the swift fox, whose low rate of uterine pathology
may be related to its relatively short luteal phase and single
annual ovulation. Regardless of number of cycles per year,
data for all canids studied to date suggest that they are
monestrous, with an anestrous period intervening between
cycles. That period of anestrous is considerably longer in
species that ovulate less frequently. However, the important
consideration for all canids, compared to other mammalian
species, is that they have relatively long periods of proestrus
and estrus when estrogen is being secreted, and long luteal
phases with elevated progesterone.
Regardless of the possible explanations, uterine
pathology, particularly in painted dogs and red wolves,
presents a very real risk to their health and their fertility. Not
only can EH predispose a female to life‐threatening pyometra
but it can render her infertile due to alterations in the uterine
endometrium that prevent or reduce the ability of the female
to maintain a pregnancy. The most effective way to prevent
EH may be by allowing females to regularly undergo
pregnancy and parturition.
This protective effect of pregnancy has also been
reported for domestic dogs [Hagman et al., 2011]. Although
progesterone is also elevated during gestation, the process of
parturition and subsequent endometrial remodeling can
return the endometrium to a baseline state. In addition,
parturition is accompanied by increased prostaglandin (that
stimulates uterine contractions) and an abrupt pre‐partum
decline in progesterone. In contrast, after the luteal phase of a
non‐pregnant cycle ends, progesterone concentrations grad-
ually decrease across days or even weeks [Concannon
et al., 1977].
Our results suggest that the number of years a female
produced a litter was associated with lower risk of EH or
pyometra, although the results for EH were not as clear,
perhaps due to the limited number of cases submitted. Also,
the number of years pregnant was not consistent across
individuals or species, so we cannot predict how frequently a
female should be allowed to reproduce. Nevertheless, spacing
pregnancies should be preferable to clustering them,
separated by long periods of contraception or separation
from males. Interrupting non‐reproductive periods with
pregnancy and parturition could help maintain uterine health.
Current reproductive management often involves delaying
first reproduction in young females or breeding annually till a
female is genetically well‐represented then recommending
against reproduction for prolonged periods. Those extended
periods without reproduction are likely to be increasing the
risks of uterine pathology in those females.
Although separating males from females may present
social and logistical problems, managers sometimes consider
that option to carry lower risk to the female’s health than
contraceptive treatment. Our results reveal that the two
contraceptives used most in canids (MGA implants and
Suprelorin®) carry a roughly equivalent risk to uterine health
compared to separation. Thus, avoiding contraception to
achieve reproductive management does not avoid the risk of
uterine pathology. In fact, a variation of the Suprelorin®
treatment protocol may be associated with lower risk.
There was an insufficient number of cases of the more
recently introduced Suprelorin® contraceptive protocol
(Suprelorin® plus 2 weeks of megestrol acetate pills
(Ovaban®) to prevent the stimulation phase) to include in
the GLM or prevalence analyses. That is especially
unfortunate, because this protocol avoids exposure to the
endogenous progesterone which would follow stimulated
ovulation. Thus, we predict that it should pose a lower risk of
uterine pathology than the other methods or than natural
cycles. Without the stimulation phase and with down‐
regulation of the pituitary gonadotrophs and the resulting
absence of the gonadal steroids that can induce EH, this
protocol should be a safer alternative. Megestrol acetate, of
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course, is itself a synthetic progestin. However, this 2‐week
treatment presents a much lower risk for two reasons. First,
2 weeks is considerably less exposure than 2 or more months.
Second and perhaps more importantly, if treatment is initiated
when a female is not in proestrus or estrus, there is no
estrogen priming, which should reduce the availability of
progestin receptors and the ability of progestin to act.
Although reversibility of Suprelorin® is not yet well‐
established, WCC studies are underway to define the
parameters of reproductive suppression following Supre-
lorin® treatment.
A possible additional concern is that some reports to the
WCC have shown or suggested considerable variability in
hormone concentrations and patterns among individuals
during the reversal phase. For example, progesterone
concentrations may be higher during the first luteal phase
during recovery, which might exacerbate any underlying
uterine pathology. Conjecture is that as levels of deslorelin
(the active ingredient of Suprelorin®) fall below the threshold
required to maintain pituitary down‐regulation, it may be
temporarily stimulatory until levels decline sufficiently to
have no effect. To counter this possibility, the WCC has
worked to develop implant insertion protocols that allow
implant removal, to hasten reversal and eliminate any
recovery phase stimulation. A link to a video illustrating
these insertion techniques can be found on the American
Association of Zoo Veterinarians (AAZV) webpage. The
WCC (in collaboration with Christensen et al. [2012]) has
developed a transcervical biopsy technique to aid in
diagnosing EH, with a hope to test treatments that might
reverse the condition and restore fertility.
Although canids might be the most likely taxon to
develop pyometra, uterine pathology in other species can
take many forms, including EH. However, there has been no
systematic study of the prevalence of uterine pathology in
other taxa except perhaps felids [Munson, 2006]. Those
analyses focused primarily on contraceptive use compared
to non‐contracepted reproductive tissues, without factoring
in years separated from males versus years producing litters.
There have been no other studies that compared treatment
with contraception to pregnancies and to separation of
genders that result in barren cycles. Yet there have been
occasional reports published for other species on uterine
pathology related to non‐reproductive years, for example,
nulliparity, in a variety of species [Hildebrandt et al., 2000;
Agnew et al., 2004; Hermes et al., 2004; Napier et al., 2009;
Crosier et al., 2011]. Given the challenge of sustainability
facing zoos, it is critical that further research be focused on
assessing reproductive health and fertility and on addressing
problems identified so that fertility can be maintained or
restored. Reproduction is a process which requires the
coordination and sequential action of many hormones
and physiological processes. Uterine health is only one of
the potential endpoints that can be measured. More
extensive monitoring and study of more of the endpoints
is central to determining to what extent reproductive failures
are due to infertility or other factors such as behavioral
incompatibility.
CONCLUSIONS
1. This study found that uterine pathology (endometrial
hyperplasia and pyometra) was associated with number of
years contracepted with two particular contraceptives (MGA
implants and Suprelorin® alone) and with number of years
barren (not producing a litter and not contracepted).
2. Years producing a litter was associated with a lower incidence
of uterine pathology.
3. Suprelorin® plus Ovaban® may protect the uterine endome-
trium by minimizing exposure to progesterone.
4. African painted dogs and red wolves seemed more suscepti-
ble to both types of uterine pathology, whereas swift and
fennec foxes seemed least susceptible.
5. Uterine pathology not only threatens a female’s health (i.e.,
pyometra) but also her fertility (endometrial hyperplasia).
6. AZA‐managed programs should consider a female’s lifetime
reproductive recommendations in order to maintain her
fertility.
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